| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.383 | 13.310 | 15.353 | - | 18.904 | 27.677 |
| Total Income - EUR | - | - | - | - | 1.386 | 13.324 | 15.354 | - | 26.003 | 50.629 |
| Total Expenses - EUR | - | - | - | - | 2.211 | 10.083 | 12.700 | - | 24.394 | 50.156 |
| Gross Profit/Loss - EUR | - | - | - | - | -826 | 3.241 | 2.655 | - | 1.609 | 473 |
| Net Profit/Loss - EUR | - | - | - | - | -867 | 2.849 | 2.194 | - | 1.419 | 313 |
| Employees | - | - | - | - | 1 | 1 | 1 | - | 1 | 1 |
Check the financial reports for the company - Inspire Bio Solutions S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 36 | 0 | 23.728 | - | 14.238 | 0 |
| Current Assets | - | - | - | - | 5.558 | 12.015 | 14.112 | - | 21.453 | 20.347 |
| Inventories | - | - | - | - | 4.003 | 8.817 | 8.538 | - | 16.886 | 15.098 |
| Receivables | - | - | - | - | 1.378 | 1.861 | 4.391 | - | 1.661 | 4.549 |
| Cash | - | - | - | - | 176 | 1.338 | 1.183 | - | 2.905 | 701 |
| Shareholders Funds | - | - | - | - | -783 | 2.081 | 4.229 | - | 267 | 578 |
| Social Capital | - | - | - | - | 84 | 83 | 81 | - | 81 | 80 |
| Debts | - | - | - | - | 6.376 | 9.934 | 33.611 | - | 35.424 | 25.412 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4789
|
|||||||||
Comments - Inspire Bio Solutions S.r.l.